Niagen Bioscience Inc (NAGE) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Niagen Bioscience Inc in 2026. The next earnings report is expected on November 4, 2026.
Next earnings date
04 Nov 2026
In 75 days
EPS estimate
0.05
Revenue estimate
36.8M
Past earnings
Latest earnings analysis
Niagen Bioscience Inc beat consensus estimates in its latest earnings report, with EPS of $0.01 versus the $0.0083 consensus and revenue of $29.79 million coming in 2.4% below expectations. In the prior quarter both EPS and revenue were also ahead of expectations.
No dividend history available.
Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.
Niagen Bioscience Inc (NAGE) is scheduled to report earnings on November 4, 2026.
Niagen Bioscience Inc (NAGE) last reported earnings on August 4, 2026.
Niagen Bioscience Inc (NAGE) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.